BioMarin Announces Fourth Quarter and Full Year 2017 Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/3/2026

1. AAPL
2. PLTR
3. CRWD
4. ON
5. VRTX
6. INSP
7. RXRX
8. CHKP
9. HNGE
10. MTCH

Go back to BioMarin Announces Fourth Quarter and Full Year 2017 Financial Results

BioMarin Pharmaceutical Inc. (BMRN) PT Raised to $100 at Citi Following 4Q

February 23, 2018 7:11 AM EST

Citi raised its price target on BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) to $100.00 (from $96.00) while maintaining a Buy rating following the company's 4Q. Results were in-line with consensus estimates on the top-line, while the bottom-line was a miss due to tax impact.

The company... More